Israel’s Novellus Hits $57 Million Series C Financing For Cancer Treatments
Novellus, Ltd., an Israeli clinical-stage biotechnology company focused on precision oncology (treatment for cancer) raised $57 million in a Series C financing round. The round was led by Pontifax, and joined by OrbiMed Advisors, HBM Healthcare Investments, Wellington Management, Cormorant Asset Management, Novartis Venture Fund (NVF), SR One, as well as existing investors. Proceeds from […]
Continue Reading